Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy
- PMID: 11148602
Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy
Abstract
Purpose: To investigate clinical factors related to the aqueous humor levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with proliferative diabetic retinopathy (PDR).
Methods: Undiluted aqueous humor was obtained during ocular surgery from 46 eyes of 46 patients and the levels of growth factors were measured using enzyme-linked immunosorbent assays. VEGF and HGF levels were compared with the number of photocoagulation. VEGF and HGF levels in patient groups stratified according to the existence of vitreous hemorrhage, retinal detachment, and fibrovascular membrane were analyzed. And clinical parameters associated with the growth factors were determined by multiple regression analysis.
Results: The levels of VEGF decreased significantly as the extent of photocoagulation increased and showed significant positive correlation with the existence of vitreous hemorrhage. There was no significant correlation between VEGF levels and the existence of fibrovascular membrane and traction retinal detachment. The levels of HGF also decreased significantly as the extent of photocoagulation increased, but increased significantly when fibrovascular membrane existed. There were no significant correlations between HGF levels and the existence of vitreous hemorrhage and traction retinal detachment. Concerning systemic conditions, each growth factor has no significant correlation with duration and type of diabetes mellitus, the treatment regimen, the control of hemoglobin A1C, and the existence of hypertension or renal dysfunction.
Conclusion: The therapeutic effect of panretinal photocoagulation on PDR might be partly exerted by reduction of the levels of VEGF and HGF in ocular fluid. Since the clinical parameters associated with VEGF were different from those associated with HGF, these growth factors might influence the progression of retinopathy in different ways.
Similar articles
-
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.N Engl J Med. 1994 Dec 1;331(22):1480-7. doi: 10.1056/NEJM199412013312203. N Engl J Med. 1994. PMID: 7526212
-
Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.Horm Metab Res. 2001 May;33(5):317-22. doi: 10.1055/s-2001-15122. Horm Metab Res. 2001. PMID: 11440280
-
Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.Exp Eye Res. 2006 May;82(5):798-806. doi: 10.1016/j.exer.2005.10.002. Epub 2005 Dec 1. Exp Eye Res. 2006. PMID: 16324700
-
Management of proliferative diabetic retinopathy.Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Compr Ophthalmol Update. 2007. PMID: 18201511 Review.
-
[Vascular endothelium-related factors and atherosclerosis/arteriosclerosis: serum hepatocyte growth factor as a possible indicator of vascular lesions].Rinsho Byori. 1998 Jul;46(7):671-7. Rinsho Byori. 1998. PMID: 9721534 Review. Japanese.
Cited by
-
Review of therapeutic advances in diabetic retinopathy.Ther Adv Endocrinol Metab. 2011 Feb;2(1):39-53. doi: 10.1177/2042018810396750. Ther Adv Endocrinol Metab. 2011. PMID: 23148170 Free PMC article.
-
Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes.J Ophthalmic Vis Res. 2020 Aug 6;15(3):341-350. doi: 10.18502/jovr.v15i3.7453. eCollection 2020 Jul-Sep. J Ophthalmic Vis Res. 2020. PMID: 32864065 Free PMC article. Review.
-
Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.Eye (Lond). 2022 Jun 7. doi: 10.1038/s41433-022-02127-x. Online ahead of print. Eye (Lond). 2022. PMID: 35672457 Review.
-
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.Arch Ophthalmol. 2007 Apr;125(4):469-80. doi: 10.1001/archopht.125.4.469. Arch Ophthalmol. 2007. PMID: 17420366 Free PMC article. Clinical Trial.
-
Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy.Clin Ophthalmol. 2012;6:185-91. doi: 10.2147/OPTH.S27423. Epub 2012 Jan 26. Clin Ophthalmol. 2012. PMID: 22331976 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical